|
|
Bottom
|
|
|
(to view contract details, including Documents, click 'Display Expanded Data Set' button, bottom right) |
| ID | Subject | Agency | Vendor | Award Date | Completion Date | Current Value(Excludes Options not Exercised) | Max Value(Includes Options not Exercised) | Competitively Procured? |
|
UTH282570
|
FY25 BPO - Hemophilia Factor Medication
|
744 - The University of Texas Health Science Center at Houston
|
NOVO NORDISK INC
|
09/10/2024
|
08/07/2025
|
$1,700,000
|
$1,700,000
|
No, non-emergency sole source procurement
|
| | | | | | | | | |
|
|
|
|
|
Top
|